{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:59:34Z","timestamp":1790402374867,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH\/NEI","award":["R01EY030513"],"award-info":[{"award-number":["R01EY030513"]}]},{"name":"NIH\/NEI","award":["P30 EY021725"],"award-info":[{"award-number":["P30 EY021725"]}]},{"name":"NIH\/NEI","award":["EY04149"],"award-info":[{"award-number":["EY04149"]}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"crossref","award":["R21AR076035"],"award-info":[{"award-number":["R21AR076035"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001298","name":"Presbyterian Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008569","name":"OCAST","doi-asserted-by":"crossref","award":["HR14-125"],"award-info":[{"award-number":["HR14-125"]}],"id":[{"id":"10.13039\/100008569","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Dean McGee Eye Institute"],"award-info":[{"award-number":["Dean McGee Eye Institute"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007732","name":"American Macular Degeneration Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Spinocerebellar ataxia 34 (SCA34) is an autosomal dominant inherited disease characterized by age-related cerebellar degeneration and ataxia caused by mutations in the <jats:italic>Elongation of Very Long Chain Fatty Acid-4<\/jats:italic> (<jats:italic>ELOVL4)<\/jats:italic> gene. The ELOVL4 enzyme catalyzes the biosynthesis of both very long chain saturated fatty acids (VLC-SFA) and very long chain polyunsaturated fatty acids (VLC-PUFA) that are important for neuronal, reproductive, and skin function. Several variants in <jats:italic>ELOVL4<\/jats:italic> have been shown to cause different tissue-specific disorders including SCA34 with or without Erythrokeratodermia Variabilis (EKV), a skin condition characterized by dry, scaly skin, Autosomal Dominant Stargardt-Like Macular Dystrophy (STGD3), and seizures associated with neuro-ichthyotic disorders. What is puzzling is how different mutations in the same gene seem to cause different tissue-specific disorders. To date, no SCA34 patients have presented with both SCA34 and STGD3 pathology that is caused by <jats:italic>ELOVL4<\/jats:italic> variants that cause truncation of ELOVL4. Here, we report a novel case of an early childhood onset and rapidly progressive cerebellar degeneration and retinal dysfunction in a Belgian-Italian girl who developed severe dysarthria and gait problems starting at about 3.5\u00a0years of age and progressed to immobility by 4.5\u00a0years of age. Brain magnetic resonance imaging (MRI) revealed progressive vermian, cerebellar, cortical atrophy, progressive corpus callosum slimming, and hot cross bun sign visible on the MRI. Ophthalmological examinations also revealed progressive macular dysfunction as measured by electroretinography. Using exome sequencing, we identified a novel heterozygous <jats:italic>ELOVL4<\/jats:italic> variant, c.503\u00a0T\u2009&gt;\u2009C (p. L168S) in the patient. To understand the enzymatic function of this novel ELOVL4 variant and how it alters the levels of VLC-PUFA and VLC-SFA biosynthesis to contribute to cerebellar and retinal dysfunction, we expressed wild-type <jats:italic>ELOVL4<\/jats:italic> or the L168S <jats:italic>ELOVL4<\/jats:italic> variant in cell culture and supplemented the cultures with VLC-PUFA or VLC-SFA precursors. We showed that the L168S ELOVL4 variant is deficient in the biosynthesis of VLC-SFA and VLC-PUFA. Our work suggests that differential depletion of these fatty acids may be a contributing factor to the pathogenic mechanism of SCA34 with or without EKV. Further studies will help further define how the different ELOVL4 variants cause different tissue-specific disorders with variable ages of onset.<\/jats:p>","DOI":"10.1186\/s40478-023-01628-4","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T10:02:19Z","timestamp":1691748139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-1915","authenticated-orcid":false,"given":"Yeboah Kofi","family":"Gyening","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6172-8247","authenticated-orcid":false,"given":"Keren","family":"Boris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-3463","authenticated-orcid":false,"given":"Mignot","family":"Cyril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8527-5315","authenticated-orcid":false,"given":"Richard S.","family":"Brush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-1611","authenticated-orcid":false,"given":"Marie-C\u00e9cile","family":"Nassogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1920-915X","authenticated-orcid":false,"given":"Martin-Paul","family":"Agbaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"8334","key":"1628_CR1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"1","author":"AE Harding","year":"1983","unstructured":"Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1(8334):1151\u20131155","journal-title":"Lancet"},{"issue":"12","key":"1628_CR2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ng.2007.43","volume":"39","author":"H Houlden","year":"2007","unstructured":"Houlden H, Johnson J, Gardner-Thorpe C, Lashley T, Hernandez D, Worth P, Singleton AB, Hilton DA, Holton J, Revesz T et al (2007) Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11. Nat Genet 39(12):1434\u20131436","journal-title":"Nat Genet"},{"issue":"1","key":"1628_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL (2019) Spinocerebellar ataxia. Nat Rev Dis Primers 5(1):24","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1628_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","volume":"124","author":"K Seidel","year":"2012","unstructured":"Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rub U (2012) Brain pathology of spinocerebellar ataxias. Acta Neuropathol 124(1):1\u201321","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1628_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/neup.12184","volume":"35","author":"T Adachi","year":"2015","unstructured":"Adachi T, Kitayama M, Nakano T, Adachi Y, Kato S, Nakashima K (2015) Autopsy case of spinocerebellar ataxia type 31 with severe dementia at the terminal stage. Neuropathology 35(3):273\u2013279","journal-title":"Neuropathology"},{"issue":"4","key":"1628_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(18)30042-5","volume":"17","author":"A Diallo","year":"2018","unstructured":"Diallo A, Jacobi H, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L et al (2018) Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study. Lancet Neurol 17(4):327\u2013334","journal-title":"Lancet Neurol"},{"issue":"5","key":"1628_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","volume":"3","author":"L Schols","year":"2004","unstructured":"Schols L, Bauer P, Schmidt T, Schulte T, Riess O (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3(5):291\u2013304","journal-title":"Lancet Neurol"},{"issue":"2","key":"1628_CR8","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000403","volume":"6","author":"M Beaudin","year":"2020","unstructured":"Beaudin M, Sellami L, Martel C, Touzel-Deschenes L, Houle G, Martineau L, Lacroix K, Lavallee A, Chrestian N, Rouleau GA et al (2020) Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34. Neurol Genet 6(2):e403","journal-title":"Neurol Genet"},{"issue":"5","key":"1628_CR9","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000357","volume":"5","author":"C Xiao","year":"2019","unstructured":"Xiao C, Binkley EM, Rexach J, Knight-Johnson A, Khemani P, Fogel BL, Das S, Stone EM, Gomez CM (2019) A family with spinocerebellar ataxia and retinitis pigmentosa attributed to an ELOVL4 mutation. Neurol Genet 5(5):e357","journal-title":"Neurol Genet"},{"issue":"4","key":"1628_CR10","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000263","volume":"4","author":"PR Bourque","year":"2018","unstructured":"Bourque PR, Warman-Chardon J, Lelli DA, LaBerge L, Kirshen C, Bradshaw SH, Hartley T, Boycott KM (2018) Novel ELOVL4 mutation associated with erythrokeratodermia and spinocerebellar ataxia (SCA 34). Neurol Genet 4(4):e263","journal-title":"Neurol Genet"},{"issue":"8","key":"1628_CR11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jamaneurol.2015.0888","volume":"72","author":"CV Bourassa","year":"2015","unstructured":"Bourassa CV, Raskin S, Serafini S, Teive HA, Dion PA, Rouleau GA (2015) A New ELOVL4 Mutation in a Case of Spinocerebellar Ataxia With Erythrokeratodermia. JAMA Neurol 72(8):942\u2013943","journal-title":"JAMA Neurol"},{"issue":"7","key":"1628_CR12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2015.0610","volume":"72","author":"K Ozaki","year":"2015","unstructured":"Ozaki K, Doi H, Mitsui J, Sato N, Iikuni Y, Majima T, Yamane K, Irioka T, Ishiura H, Doi K et al (2015) A novel mutation in ELOVL4 leading to Spinocerebellar ataxia (SCA) with the hot cross bun sign but lacking erythrokeratodermia: a broadened spectrum of SCA34. JAMA Neurol 72(7):797\u2013805","journal-title":"JAMA Neurol"},{"issue":"4","key":"1628_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2013.6337","volume":"71","author":"M Cadieux-Dion","year":"2014","unstructured":"Cadieux-Dion M, Turcotte-Gauthier M, Noreau A, Martin C, Meloche C, Gravel M, Drouin CA, Rouleau GA, Nguyen DK, Cossette P (2014) Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia. JAMA Neurol 71(4):470\u2013475","journal-title":"JAMA Neurol"},{"key":"1628_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100030","volume":"62","author":"GK Yeboah","year":"2021","unstructured":"Yeboah GK, Lobanova ES, Brush RS, Agbaga MP (2021) Very long chain fatty acid-containing lipids: a decade of novel insights from the study of ELOVL4. J Lipid Res 62:100030","journal-title":"J Lipid Res"},{"issue":"6","key":"1628_CR15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ajhg.2011.10.011","volume":"89","author":"MA Aldahmesh","year":"2011","unstructured":"Aldahmesh MA, Mohamed JY, Alkuraya HS, Verma IC, Puri RD, Alaiya AA, Rizzo WB, Alkuraya FS (2011) Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia. Am J Hum Genet 89(6):745\u2013750","journal-title":"Am J Hum Genet"},{"key":"1628_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2350-15-25","volume":"15","author":"H Mir","year":"2014","unstructured":"Mir H, Raza SI, Touseef M, Memon MM, Khan MN, Jaffar S, Ahmad W (2014) A novel recessive mutation in the gene ELOVL4 causes a neuro-ichthyotic disorder with variable expressivity. BMC Med Genet 15:25","journal-title":"BMC Med Genet"},{"issue":"35","key":"1628_CR17","doi-asserted-by":"crossref","first-page":"12843","DOI":"10.1073\/pnas.0802607105","volume":"105","author":"MP Agbaga","year":"2008","unstructured":"Agbaga MP, Brush RS, Mandal MN, Henry K, Elliott MH, Anderson RE (2008) Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc Natl Acad Sci USA 105(35):12843\u201312848","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1628_CR18","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1194\/jlr.M007518","volume":"51","author":"A Liu","year":"2010","unstructured":"Liu A, Chang J, Lin Y, Shen Z, Bernstein PS (2010) Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration. J Lipid Res 51(11):3217\u20133229","journal-title":"J Lipid Res"},{"issue":"37","key":"1628_CR19","doi-asserted-by":"crossref","first-page":"32521","DOI":"10.1074\/jbc.M503411200","volume":"280","author":"C Grayson","year":"2005","unstructured":"Grayson C, Molday RS (2005) Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4. J Biol Chem 280(37):32521\u201332530","journal-title":"J Biol Chem"},{"issue":"2","key":"1628_CR20","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s12035-017-0824-8","volume":"55","author":"BR Hopiavuori","year":"2018","unstructured":"Hopiavuori BR, Deak F, Wilkerson JL, Brush RS, Rocha-Hopiavuori NA, Hopiavuori AR, Ozan KG, Sullivan MT, Wren JD, Georgescu C et al (2018) Homozygous expression of mutant ELOVL4 leads to seizures and death in a novel animal model of very long-chain fatty acid deficiency. Mol Neurobiol 55(2):1795\u20131813","journal-title":"Mol Neurobiol"},{"key":"1628_CR21","first-page":"100317","volume":"2022","author":"YK Gyening","year":"2022","unstructured":"Gyening YK, Chauhan NK, Tytanic M, Ea V, Brush RS, Agbaga MP (2022) ELOVL4 mutations that cause spinocerebellar ataxia-34 differentially alter very long chain fatty acid biosynthesis. J Lipid Res 2022:100317","journal-title":"J Lipid Res"},{"issue":"11","key":"1628_CR22","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1007\/s12035-020-02052-8","volume":"57","author":"MP Agbaga","year":"2020","unstructured":"Agbaga MP, Stiles MA, Brush RS, Sullivan MT, Machalinski A, Jones KL, Anderson RE, Sherry DM (2020) The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration. Mol Neurobiol 57(11):4735\u20134753","journal-title":"Mol Neurobiol"},{"key":"1628_CR23","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1007\/s12035-021-02439-1","volume":"58","author":"RY Nagaraja","year":"2021","unstructured":"Nagaraja RY, Sherry DM, Fessler JL, Stiles MA, Li F, Multani K, Orock A, Ahmad M, Brush RS, Anderson RE et al (2021) W246G mutant ELOVL4 impairs synaptic plasticity in parallel and climbing fibers and causes motor defects in a rat model of SCA34. Mol Neurobiol 58:4921","journal-title":"Mol Neurobiol"},{"issue":"9","key":"1628_CR24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","volume":"9","author":"A Durr","year":"2010","unstructured":"Durr A (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 9(9):885\u2013894","journal-title":"Lancet Neurol"},{"issue":"5","key":"1628_CR25","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1167\/iovs.14-13995","volume":"55","author":"LD Bennett","year":"2014","unstructured":"Bennett LD, Brush RS, Chan M, Lydic TA, Reese K, Reid GE, Busik JV, Elliott MH, Anderson RE (2014) Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors. Invest Ophthalmol Vis Sci 55(5):3150\u20133157","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"1628_CR26","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1212\/WNL.30.12.1303","volume":"30","author":"JW Lance","year":"1980","unstructured":"Lance JW (1980) The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology 30(12):1303\u20131313","journal-title":"Neurology"},{"issue":"10","key":"1628_CR27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/jnnp.41.10.865","volume":"41","author":"J Van Gijn","year":"1978","unstructured":"Van Gijn J (1978) The Babinski sign and the pyramidal syndrome. J Neurol Neurosurg Psychiatry 41(10):865\u2013873","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1628_CR28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","volume":"144","author":"AG Robson","year":"2022","unstructured":"Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M, Li S, McCulloch DL (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144(3):165\u2013177","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"1628_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1\u201312","journal-title":"Doc Ophthalmol"},{"issue":"4","key":"1628_CR30","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1194\/jlr.M045443","volume":"55","author":"S Logan","year":"2014","unstructured":"Logan S, Agbaga MP, Chan MD, Brush RS, Anderson RE (2014) Endoplasmic reticulum microenvironment and conserved histidines govern ELOVL4 fatty acid elongase activity. J Lipid Res 55(4):698\u2013708","journal-title":"J Lipid Res"},{"issue":"14","key":"1628_CR31","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1073\/pnas.1217251110","volume":"110","author":"S Logan","year":"2013","unstructured":"Logan S, Agbaga MP, Chan MD, Kabir N, Mandal NA, Brush RS, Anderson RE (2013) Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy. Proc Natl Acad Sci USA 110(14):5446\u20135451","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"1628_CR32","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1007\/s12035-021-02439-1","volume":"58","author":"RY Nagaraja","year":"2021","unstructured":"Nagaraja RY, Sherry DM, Fessler JL, Stiles MA, Li F, Multani K, Orock A, Ahmad M, Brush RS, Anderson RE et al (2021) W246G Mutant ELOVL4 Impairs Synaptic Plasticity in Parallel and Climbing Fibers and Causes Motor Defects in a Rat Model of SCA34. Mol Neurobiol 58(10):4921\u20134943","journal-title":"Mol Neurobiol"},{"issue":"6","key":"1628_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2017739118","volume":"118","author":"A Gorusupudi","year":"2021","unstructured":"Gorusupudi A, Rallabandi R, Li B, Arunkumar R, Blount JD, Rognon GT, Chang FY, Wade A, Lucas S, Conboy JC et al (2021) Retinal bioavailability and functional effects of a synthetic very-long-chain polyunsaturated fatty acid in mice. Proc Natl Acad Sci USA 118(6):1","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1628_CR34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1194\/jlr.M021386","volume":"53","author":"M Yu","year":"2012","unstructured":"Yu M, Benham A, Logan S, Brush RS, Mandal MNA, Anderson RE, Agbaga MP (2012) ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3. J Lipid Res 53(3):494\u2013504","journal-title":"J Lipid Res"},{"key":"1628_CR35","doi-asserted-by":"crossref","unstructured":"Nishide M, Le Marquand K, Davis MR, Halmagyi GM, Fellner A, Narayanan RK, Kennerson ML, Reddel SW, Worgan L, Panegyres PK et al (2023) Two new families and a literature review of ELOVL4-associated Spinocerebellar ataxia type 34. Cerebellum","DOI":"10.1007\/s12311-023-01522-8"},{"issue":"1","key":"1628_CR36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0003-2697(75)90572-2","volume":"69","author":"T Chojnacki","year":"1975","unstructured":"Chojnacki T, Jankowski W, Mankowski T, Sasak W (1975) Preparative separation of naturally occurring mixtures of polyprenols on hydroxyalkoxypropyl-Sephadex. Anal Biochem 69(1):114\u2013119","journal-title":"Anal Biochem"},{"issue":"1","key":"1628_CR37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1086\/302958","volume":"67","author":"A Herman-Bert","year":"2000","unstructured":"Herman-Bert A, Stevanin G, Netter JC, Rascol O, Brassat D, Calvas P, Camuzat A, Yuan Q, Schalling M, Durr A et al (2000) Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3\u2013q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet 67(1):229\u2013235","journal-title":"Am J Hum Genet"},{"key":"1628_CR38","volume":"9","author":"X Meng","year":"2021","unstructured":"Meng X, Long Y, Ren J, Wang G, Yin X, Li S (2021) Ocular Characteristics of Patients With Bardet-Biedl Syndrome Caused by Pathogenic BBS Gene Variation in a Chinese Cohort. Front Cell Dev Biol 9:635216","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"1628_CR39","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1167\/iovs.06-0517","volume":"47","author":"AA Azari","year":"2006","unstructured":"Azari AA, Aleman TS, Cideciyan AV, Schwartz SB, Windsor EA, Sumaroka A, Cheung AY, Steinberg JD, Roman AJ, Stone EM et al (2006) Retinal disease expression in Bardet-Biedl syndrome-1 (BBS1) is a spectrum from maculopathy to retina-wide degeneration. Invest Ophthalmol Vis Sci 47(11):5004\u20135010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1628_CR40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.6061\/clinics\/2012(02)09","volume":"67","author":"A Berezovsky","year":"2012","unstructured":"Berezovsky A, Rocha DM, Sacai PY, Watanabe SS, Cavascan NN, Salomao SR (2012) Visual acuity and retinal function in patients with Bardet-Biedl syndrome. Clinics (Sao Paulo) 67(2):145\u2013149","journal-title":"Clinics (Sao Paulo)"},{"key":"1628_CR41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archpedi.1961.02080010207009","volume":"102","author":"AE Krill","year":"1961","unstructured":"Krill AE, Folk E, Rosenthal IM (1961) Electroretinography in the Laurence-Moon-Biedl syndrome. An aid in diagnosis of the atypical case. Am J Dis Child 102:205\u2013209","journal-title":"Am J Dis Child"},{"key":"1628_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.57358","volume":"9","author":"JY Hsieh","year":"2020","unstructured":"Hsieh JY, Ulrich BN, Issa FA, Lin MA, Brown B, Papazian DM (2020) Infant and adult SCA13 mutations differentially affect Purkinje cell excitability, maturation, and viability in vivo. Elife 9:1","journal-title":"Elife"},{"issue":"10","key":"1628_CR43","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.chembiol.2012.07.013","volume":"19","author":"AW Kasumu","year":"2012","unstructured":"Kasumu AW, Hougaard C, Rode F, Jacobsen TA, Sabatier JM, Eriksen BL, Strobaek D, Liang X, Egorova P, Vorontsova D et al (2012) Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2. Chem Biol 19(10):1340\u20131353","journal-title":"Chem Biol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01628-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01628-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01628-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T17:30:01Z","timestamp":1700587801000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01628-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1628"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01628-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Appropriate intuitional approval and written consent was obtained from the patient\u2019s family for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the submission and publication of this manuscript was obtained from the parents of the case study patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}